Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amiot

Showing results (791-800 of 823) with videos related to

Pageof 83
Sort By:
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2020
<i>Ex Vivo</i> Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver FailureClara T Nicolas, Robert A Kaiser, Raymond D Hickey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2020
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID studyThomas Lambin, Aurélien Amiot, Carmen Stefanescu, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2024
Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort StudyGuillaume Le Cosquer, Julien Kirchgesner, Cyrielle Gilletta De Saint Joseph, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Pageof 83

Showing results (791-800 of 823) with videos related to

Sort By:
Pageof 83
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2020
<i>Ex Vivo</i> Cell Therapy by Ectopic Hepatocyte Transplantation Treats the Porcine Tyrosinemia Model of Acute Liver FailureClara T Nicolas, Robert A Kaiser, Raymond D Hickey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 23, 2020
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID studyThomas Lambin, Aurélien Amiot, Carmen Stefanescu, et al.
United European Gastroenterology Journal|March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAIDLouis Calméjane, Catherine Reenaers, Claire Gay, et al.
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2024
Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort StudyGuillaume Le Cosquer, Julien Kirchgesner, Cyrielle Gilletta De Saint Joseph, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or CyclosporineDavid Laharie, Arnaud Bourreille, Julien Branche, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Pageof 83